glp-1 효과 갈수록 뚱뚱해지는 호모 사피엔스(Homo sapiens): 요법에 대한 WHO 권고 (上) < 정재훈 소장│청론보건연구소 < 정기연재 < 오피니언 < 기사본문 Glucagon like peptide-1 (GLP-1) 수용체
Description
Three FDA-approved medications are covered: Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron, the first oral GLP-1 pill for weight loss)
The same dose does not produce identical effects in a 240-pound man and a 150-pound woman
Increased thirst is not officially listed as a direct side effect in FDA prescribing information, but some patients report it anecdotally
People taking them consistently describe a quieting
Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, et al
Built for Subscription and Lifetime Value Models
